Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis - Part 2 - Voice4PD-MSA-II

Status: Unknown
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Parkinson's disease (PD) is the second most common neurodegenerative disease. Multiple system atrophy (MSA) is a relentlessly progressing rare neurodegenerative disease of unknown etiology. The differential diagnosis between the MSA-Parkinsonism (MSA-P) subtype and PD can be very challenging in early disease stages, while early diagnostic certitude is important for the patient because of the diverging prognosis. At the time being, there exists no validated objective biomarker to guide the clinician. Dysarthria is a common early symptom in both diseases and of different origin. The ambition and the originality of this project are to develop a digital voice-based tool for objective discrimination between PD and MSA-P.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 80
Healthy Volunteers: t
View:

⁃ Age from 30 to 80 years old

• Signed informed consent

• Affiliated to social security

• Patient with PD :

∙ Diagnosis of idiopathic Parkinson's disease (PD) according to criteria (Postuma et al., 2015)

‣ Patient PD : Hoehn\&Yahr stage between 1 and 2

‣ Patient with or without mild to moderate speech troubles: MDS-UPDRS III item 1 ≤ 2

• Patients with MSA-P :

∙ Diagnosis of Multiple Atrophy System (MSA) Parkinsonian form possible or probable according to current consensus criteria (Gilman et al., 2008)

‣ Patient MSA-P: score of part IV of the UMSARS ≤ 3 points

‣ Patient with or without mild to moderate speech troubles: UMSARS II item 2 ≤ 2

• Controls :

∙ Absence of neurologic and oto-rhino-laryngologic disease

Locations
Other Locations
France
CHU de Bordeaux - Institut des maladies neurodégénératives de Bordeaux
RECRUITING
Bordeaux
Centre Hospitalier Universitaire de Toulouse
RECRUITING
Toulouse
Contact Information
Primary
Wassilios MEISSNER, MD, PhD
wassilios.meissner@chu-bordeaux.fr
+335 57 82 12 53
Backup
Sandrine VILLARS
sandrine.villars@chu-bordeaux.fr
+335 57 82 12 53
Time Frame
Start Date: 2023-03-21
Completion Date: 2024-01-02
Participants
Target number of participants: 60
Treatments
Experimental: Parkinson's disease
Diagnosis of idiopathic Parkinson's disease (PD) according to MDS criteria (Postuma et al., 2015)
Experimental: Multiple system atrophy parkinsonian subtype (MSA-P)
Diagnosis of Multiple Atrophy System (MSA-P) Parkinsonian form possible or probable according to consensus criteria (Gilman et al., 2008)
Experimental: Healthy volunteer
Absence of neurologic and oto-rhino-laryngologic disease
Sponsors
Collaborators: Institut National de Recherche en Informatique et en Automatique
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov